By the GLP Chart editors. How we check. How we make money. Some visit links earn us a commission.

GLP-1 cash price index: $299 a month in October 2026

The median US GLP-1 telehealth program charged $299 a month in October 2026, unchanged across the 20 programs priced in both September and October, according to GLP Chart's GLP-1 Cash Price Index, published November 2, 2026. The cheapest verified compounded semaglutide route was $76 and the cheapest verified branded route $299.

Buying rather than citing? Collective is the cheapest cash route on the chart, from $76 a month with the $199 yearly membership averaged in. That price buys compounded semaglutide, a pharmacy-made version that is not FDA-approved and is not Wegovy, Ozempic, Zepbound or Mounjaro.

Check price →

The three numbers

MeasureOctober 2026Month on monthWhere it comes from
Median all-in cash price
34 programs priced in October, 20 in both months
$299/mounchanged (0%)Median of the weekly medians across every program priced in the month; the change counts only programs priced in both months.
Cheapest compounded semaglutide
Collective
$76/mounchanged (0%)Median of the weekly floors across programs publishing one flat all-in monthly price for compounded semaglutide at every dose.
Cheapest branded route
Knownwell
$299/mounchanged (0%)Median of the weekly floors across branded-supply programs with verified maintenance pricing.
Why you can trust GLP Chart. Same scoring framework applied to every program, and payment never changes a score. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every week.

The gap between the two routes was $223 a month in October 2026. Branded cost 3.93x the compounded route. Compounded medications are not FDA-approved products, and they are not the same product as the branded drug.

What moved in October 2026

3 tracked prices moved. Each was read off the program's own published page on the date shown.

ProgramWasNowChecked
Medvi$299/mo$199/moOctober 26, 2026
Strut Health$149/mo$129/moOctober 26, 2026
yourEra$99/mo$89/moOctober 26, 2026

Who joined and who left

The change from September counts only programs priced in both months. The rest are named here.

  • Joined. bmiMD at $159/mo, first priced October 12, 2026.
  • Joined. Collective at $76/mo, first priced October 12, 2026.
  • Joined. Direct Meds at $297/mo, first priced October 12, 2026.
  • Joined. EverPrime at $249/mo, first priced October 26, 2026.
  • Joined. GoodLife Health at $598/mo, first priced October 12, 2026.
  • Joined. MEDGm at $299/mo, first priced October 12, 2026.
  • Joined. Ongo Weight Loss at $249/mo, first priced October 26, 2026.
  • Joined. Peter MD at $149/mo, first priced October 26, 2026.
  • Joined. SkinnyRx at $249/mo, first priced October 26, 2026.
  • Joined. SnagRx at $99/mo, first priced October 12, 2026.
  • Joined. Sprout Health at $161/mo, first priced October 12, 2026.
  • Joined. Wellorithm at $247/mo, first priced October 26, 2026.
  • Joined. yourEra at $99/mo, first priced October 12, 2026.
  • Joined. Yucca Health at $89/mo, first priced October 12, 2026.
  • Left. Mochi Health was delisted on September 14, 2026. It was $178/mo in September.
  • As published. The October 2026 release put the September median at $333 under method 2.0, and that page stands unchanged.

What a pharmacy pays for the same month

The CMS National Average Drug Acquisition Cost survey records what US retail pharmacies pay their wholesaler. It is an acquisition-cost benchmark. It is not pharmacy margin: the distance to a cash price also covers dispensing, the clinician visit, shipping and the seller's own costs, and a manufacturer selling direct does not buy through a wholesaler at all. NADAC dashboards have been published free by 46brooklyn Research since 2019. What is added here is the join to verified consumer cash prices.

DrugPharmacy acquisition, a monthCheapest verified cash
Wegovy
NADAC effective August 19, 2026
$1,302 to $1,307$299/mo
Sam's Club Member Health
Zepbound
NADAC effective August 19, 2026
$482 to $1,052$449/mo
Ro Body

A month of branded Wegovy cost a US pharmacy $1,302 to acquire in October 2026, against $299 for the cheapest verified cash route in this index, according to GLP Chart's reading of the CMS NADAC file effective August 19, 2026.

Packaging, same drug, same dose

Lilly sells Zepbound as single-dose pens and as a multi-dose KwikPen. At the same dose a pharmacy pays different money for each.

DoseMulti-dose KwikPenSingle-dose pensGap
Zepbound 2.5 mg$482/mo$1,052/mo2.18x
Zepbound 5 mg$482/mo$1,052/mo2.18x
Zepbound 7.5 mg$482/mo$1,052/mo2.18x
Zepbound 10 mg$675/mo$1,052/mo1.56x
Zepbound 12.5 mg$678/mo$1,052/mo1.55x
Zepbound 15 mg$672/mo$1,051/mo1.56x

The series

One row per month since the weekly record opened. The monthly value is the median of that month's weekly checks. Earlier months are recomputed on today's corrected record, so a row can differ from the figure an earlier release published.

MonthMedian all-inCompounded floorBranded floorChecks
May 2026$299/mo$209/mo$299/mo1
June 2026$299/mo$209/mo$299/mo5
July 2026$307/mo$198/mo$299/mo4
August 2026$322/mo$198/mo$299/mo5
September 2026$333/mo$198/mo$299/mo4
October 2026$299/mo$76/mo$299/mo4

Method, version 2.0

Unchanged since the October 2026 release, which sets it out in full.

Prices are checked every week. Full method on the methodology page.

Revisions

None. This release is at revision 1, published November 2, 2026. A published number on this page is never edited in place. A correction becomes a new revision, listed here, with the old value kept.

Download and cite this release

Published under Creative Commons CC BY 4.0. Reuse any number with attribution. Nothing here asks for an account or an email address.

GLP-1 Cash Price Index, November 2026 release (October 2026 data), GLP Chart, method version 2.0. glpchart.com/price-index/2026-11/

CSV, JSON, chart embed, press kit

Any cut of this data by state, drug or program, within 24 hours: press@glpchart.com.

Every release